Skip to main content

Market Overview And Baidu Lead The Nasdaq-100 In A Mixed Day Of Trading

Share: And Baidu Lead The Nasdaq-100 In A Mixed Day Of Trading

U.S. indices were trading higher Tuesday on continued strength as investors await the Fed's Jackson Hole Economic Policy Symposium this week. The recent FDA approval of Pfizer's (NYSE: PFE) COVID-19 vaccine has also helped lift stocks in reopening sectors.

  • The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.31% to $374.37
  • The SPDR Dow Jones Industrial Average ETF Trust (NASDAQ: DIA) finished higher by 0.08% to $353.74
  • The SPDR S&P 500 ETF Trust (NASDAQ: SPY) gained 0.16% to $447.97

Here are the day's winners and losers from the Nasdaq-100, according to data from Benzinga Pro.

JD.Com Inc (NASDAQ: JD), Baidu Inc (NASDAQ: BIDU) and NetEase Inc (NASDAQ: NTES) were among the top gainers for the Nasdaq-100 Tuesday.

Moderna Inc (NASDAQ: MRNA), Analog Devices, Inc. (NASDAQ: ADI) and Maxim Integrated Products Inc. (NASDAQ: MXIM) were among the top losers.

Elsewhere On The Street

Wall Street saw something Tuesday it hasn't seen in months: GameStop Corp (NYSE: GME) up more than 20% in a trading day. The last time GameStop's stock had this big of a move was back in early June... Read More

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said Monday the automaker’s Full Self Driving Beta 9.2 was “actually not great” but things are much improved in the next version... Read More

Exactly 10 years ago today, Tim Cook took over as CEO of Apple, Inc. (NASDAQ: AAPL) for iconic visionary Apple co-founder Steve Jobs... Read More


Related Articles (QQQ)

View Comments and Join the Discussion!

Posted-In: News After-Hours Center Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at